Pending changes to Medicare in the Deficit Reduction Act of 2005 call for nonhospital outpatient technical fee reimbursement to be the lesser amount of either the Hospital Outpatient Prospective Payment System (HOPPS) or the physician fee schedule.
Pending changes to Medicare in the Deficit Reduction Act of 2005 call for nonhospital outpatient technical fee reimbursement to be the lesser amount of either the Hospital Outpatient Prospective Payment System (HOPPS) or the physician fee schedule. The problem is these are two entirely different systems, and one methodology cannot be used as a payment mechanism for the other, according to Pam Kassing, senior director of the American College of Radiology department of economics and health policy.
The physician fee schedule, developed by the Centers for Medicare and Medicaid Services more than 20 years ago, is a resource-based relative value scale (RBRVS) for determining practice expenses. The three components of RBRVS are physician work, practice expense (direct and indirect), and malpractice. Each component is adjusted to reflect different costs for different geographic areas.
Under HOPPS, Medicare pays for hospital outpatient services on a rate-per-service basis that varies according to the ambulatory payment classification (APC) group to which the service is assigned. Each APC weight represents the median hospital cost of the services. Unlike the physician fee schedule, HOPPS and APC are not resource-based systems. They are more akin to accounting procedures, and their payment rates vary from hospital to hospital and even from cost center to cost center.
http://diagnosticimaging.com
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.